Xeriant (XERI) Common Equity (2010 - 2026)

Xeriant has disclosed Common Equity across 17 years of filings, most recently posting -$5.8 million for Q1 2026.

• Common Equity for Q1 2026 came in at -$5.8 million, up 32.55% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.8 million (up 32.55% YoY), and the FY2025 annual result was -$5.8 million, up 32.38% from the prior year.
• Common Equity came in at -$5.8 million for Q1 2026 at Xeriant, down from -$5.6 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of -$669618.0 in Q1 2022 to a low of -$8.7 million in Q4 2024.
• The 5-year median for Common Equity is -$6.1 million (2023), against an average of -$6.4 million.
• Across the five-year window, Common Equity slumped 4588.35% in 2022 and soared 35.13% in 2025, its largest moves.
• Xeriant's Common Equity stood at -$5.9 million in 2022, then plunged by 32.98% to -$7.8 million in 2023, then dropped by 10.72% to -$8.7 million in 2024, then jumped by 35.13% to -$5.6 million in 2025, then declined by 2.8% to -$5.8 million in 2026.
• The last three Common Equity figures came in at -$5.8 million (Q1 2026), -$5.6 million (Q4 2025), and -$5.7 million (Q3 2025), per Business Quant data.